FINE N SCOTT 4
4 · Cyclo Therapeutics, Inc. · Filed Oct 23, 2023
Insider Transaction Report
Form 4
FINE N SCOTT
Director
Transactions
- Exercise of In-Money
Common Stock
2023-10-20$0.71/sh+299,402$212,575→ 743,804 total - Exercise of In-Money
Warrant to Purchase Common Stock
2023-10-20$0.13/sh−299,402$37,425→ 0 totalExercise: $0.71From: 2023-04-20Exp: 2030-04-20→ Common Stock (299,402 underlying) - Purchase
Warrant to Purchase Common Stock
2023-10-20+329,342→ 329,342 totalExercise: $0.95From: 2023-10-20Exp: 2027-10-20→ Common Stock (329,342 underlying)
Footnotes (1)
- [F1]The Reporting Person exercised vested Warrants (the "Original Warrants") to purchase 299,402 shares of the Issuer's common stock pursuant to a Securities Purchase Agreement dated October 20, 2023 ("Closing Date"). The Reporting Person exercised his Original Warrant in full on or prior to the Closing Date in consideration of the receipt of new warrants with an exercise price equal to $0.95 per share, to purchase 110% of the shares of the Issuer's common stock covered under the Original Warrants.